National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials (PDQ®)
Patient Version   Health Professional Version
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Maintenance Rituximab for Follicular Lymphoma

Azacitidine Improves Survival in MDS

Second Stem Cell Transplant Not Helpful in Myeloma
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

Basic Trial Information
Trial Description
     Summary
     Eligibility Criteria
Trial Contact Information

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IITreatmentActive18 and overPharmaceutical / IndustryCA184-041
NCT00527735

Trial Description

Summary

The purpose of the study is to see if ipilimumab given with paclitaxel/carboplatin will have clinical benefit when compared to paclitaxel/carboplatin alone in previously untreated patients with lung cancer

Eligibility Criteria

Inclusion Criteria:

  • Documented NSCLC or SCLC
  • ECOG of 0 or 1

Exclusion Criteria:

  • Brain metastases
  • Autoimmune disease
  • Known HIV, Hep B or Hep C infection
  • Peripheral neuropathy ≥ grade 2

Trial Contact Information

Trial Lead Organizations/Sponsors

Bristol-Myers Squibb Company - New York

Bristol-Myers SquibbStudy Director

For participation information at a USA site use a phone number below. For site information outside the USA please email:
  Email: Clinical.Trials@bms.com

First line of email MUST contain NCT# & Site#. Only trial sites that are recruiting have contact information at this time.

Trial Sites

U.S.A.
Alabama
  Birmingham
 Birmingham Hematology & Oncology Assoc. Llc
 Shailendra Lakhanpal, Site 126
Arizona
  Scottsdale
 Mayo Clinic Scottsdale
 Helen Ross, Site 122
  Tucson
 Arizona Clinical Research Center, Incorporated
 Manuel R. Modiano, Site 129 Ph: 520-290-8830
California
  Corona
 Compassionate Cancer Care Medical Group Incorporated - Corona
 Haresh S. Jhangiani, Site 059
  Fountain Valley
 Compassionate Cancer Care Medical Group Incorporated - Fountain Valley
 An D. Nguyen, Site 124
  Los Angeles
 The Angeles Clinic & Research Institute, Inc
 Omid Hamid, Site 125 Ph: 310-294-0438
  Montebello
 Oncology Care Medical Associates - Montebello
 Ira Felman, Site 057
  Portland
 Providence Portland Medical Center
 Eric Bernstein, Site 109
  Riverside
 Compassionate Cancer Care Medical Group
 Evangeline Reyes, Site 123
  San Diego
 Sharp Memorial Hospital Cancer Center
 David Bodkin, Site 055
Florida
  Boynton Beach
 Hematology & Medical Oncology
 Roger A. Brito, Site 080
  Orlando
 M.D. Anderson Cancer Center at Orlando
 Jennifer Tseng, Site 082
Georgia
  Atlanta
 Georgia Cancer Specialists - Northside Office
 Mansoor Saleh, Site 119
Illinois
  Chicago
 University of Chicago Cancer Research Center
 Everett Vokes, Site 106
  Naperville
 Hematology Oncology Consultants - Naperville
 Dennis L. Azuma, Site 056
Kentucky
  Hazard
 Kentucky Cancer Clinic - Hazard
 Hassan H. Ghazal, Site 121 Ph: 606-439-2239
Maryland
  Hagerstown
 The John R. Marsh Cancer Center
 Michael Mccormack, Site 110
Massachusetts
  Boston
 Massachusetts General Hospital
 Thomas Lynch, Site 128
Michigan
  Flint
 Genesys Hurley Cancer Institute
 Roger Black, Site 084
Minnesota
  Minneapolis
 The Cancer Center
 Arkadiusz Dudek, Site 101 Ph: 612-626-6541
Missouri
  St. Louis
 Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
 Ramaswamy Govindan, Site 113
Nevada
  Las Vegas
 Nevada Cancer Institute
 Lin-Chi Chen, Site 137
New Hampshire
  Lebanon
 Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
 James Rigas, Site 107
New York
  Mineola
 Winthrop University Hospital Oncology Hematology Division
 Jeffrey G. Schneider, Site 111
North Carolina
  Concord
 NorthEast Oncology Associates - Concord
 Garry Schwartz, Site 138
  Hickory
 Carolina Oncology Specialists
 Richard Orlowski, Site 131
Ohio
  Canton
 Gabrail Cancer Center - Canton Office
 Nashat Gabrail, Site 120
  Columbus
 Hematology Oncology Consultants, Incorporated
 Leslie R. Laufman, Site 081
  Sylvania
 Flower Hospital Cancer Center
 Rex Mowat, Site 116 Ph: 419-824-1842
Pennsylvania
  Langhorne
 St. Mary Regional Cancer Center
 Robert E. Reilly, Site 105
  Sayre
 Guthrie Cancer Center at Guthrie Clinic Sayre
 Edward O'Brien, Site 075 Ph: 800-836-0388
South Carolina
  Columbia
 Veterans Affairs Medical Center - Columbia
 Patricia Wood, Site 100
  Sumter
 Santee Hematology Oncology
 Billy Clowney, Site 127 Ph: 803-934-8833
Texas
  Lubbock
 UMC Southwest Cancer and Research Center
 Cynthia Jumper, Site 104
France
  Belfort
 Local Institution
 Site 078
  Marseille Cedex 9
 Local Institution
 Site 019
  Rennes Cedex 9
 Local Institution
 Site 062
Germany
  Bochum
 Local Institution
 Site 136
  Coswig
 Local Institution
 Site 135
  Ebensfeld
 Local Institution
 Site 025
  Grosshansdorf
 Local Institution
 Site 021
  Halle (Saale)
 Local Institution
 Site 029
  Hamburg
 Local Institution
 Site 026
  Koeln
 Local Institution
 Site 024
  Leipzig
 Local Institution
 Site 030
  Mainz
 Local Institution
 Site 027
  Muenchen
 Local Institution
 Site 023
India
  Hyderabad
 Local Institution
 Site 051
  Manipal
 Local Institution
 Site 052
  Navrangpura, Ahmedabad
 Local Institution
 Site 053
  Trivandrum
 Local Institution
 Site 050
  Vellore
 Local Institution
 Site 076
Italy
  Genova
 Local Institution
 Site 035
  Pavia
 Local Institution
 Site 132
  Siena
 Local Institution
 Site 032
  Torino
 Local Institution
 Site 034
Poland
  Gdansk
 Local Institution
 Site 010
  Krakow
 Local Institution
 Site 009
  Olsztyn
 Local Institution
 Site 139
  Szczecin
 Local Institution
 Site 011
Russia
  Arkhangelsk
 Local Institution
 Site 049
  Chelyabinsk
 Local Institution
 Site 069
  Ivanovo
 Local Institution
 Site 068
  Nizhniy Novogrod
 Local Institution
 Site 141
  Pyatigorsk
 Local Institution
 Site 060
  Sochi
 Local Institution
 Site 140
  St. Petersburg
 Site 142
 Site 064
 Site 063
 Local Institution
 Site 048
  Tomsk
 Local Institution
 Site 073
Ukraine
  Dnipropetrovsk
 Local Institution
 Site 093
  Kharkov
 Local Institution
 Site 090
  Lviv
 Local Institution
 Site 087
  Ternopol
 Local Institution
 Site 089
  Uzhgorod
 Local Institution
 Site 086

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00527735
Information obtained from ClinicalTrials.gov on May 07, 2009

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.

Back to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov